A new report by Visiongain predicts that the world antithrombotic drug market will reach revenue of $24.3 billion in 2015.
A new report by visiongain predicts that the world market for AMD and DR drugs will reach $6.25bn in 2015. That revenue forecast and others appear in Macular Degeneration (AMD) and Diabetic Retinopathy (DR): World Drug Market 2013-2023.
LONDON, UK. : new report by visiongain predicts that the world market for drugs to relieve pain will reach $61.6 billion for 2012. That revenue forecast appears in World Pain Relieving Drug Market 2012-2022, published in September 2012.
WinterGreen Research’s new report “Breath Analyzer Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018” is now available at ReportsnReports.com
BCC Research’s new report “Antibody Drugs: Technologies and Global Markets” is now available at ReportsnReports.com
Espicom Limited’s new report “Evolution in the Pain Therapy Drugs Market : Nociceptive and Neuropathic Drug Development” is now available at ReportsnReports.com.
The global top 10 drug discovery technologies market is expected to be around $ 30.8 billion in 2010 and estimated to reach $ 54 billion mark in 2015, growing at a CAGR of 11.9 % from 2010-2015
The ‘Top 10 drug discovery technologies – strategic analysis and global forecasts (2010 to 2015)’ analyzes the top 10 drug discovery technologies with respect to market drivers
The market for drug-device combination was over $9 billion in 2008 and is expected to grow at a double digit CAGR in the next few years.
By Visiongain Ltd.
– high therapeutic demands and technological challenges, with significant market potential The multiple sclerosis (MS) treatments market is one of the largest for CNS disorders, with total pharmaceutical revenues of over $8bn in 2009. upwards.